About Us

About the Hepatobiology & Toxicology research center

The Hepatobiology & Toxicology COBRE is a unique thematic research center. UofL’s COBRE scientists comprise a multidisciplinary group of investigators focusing on mechanisms and therapy for liver injury, nutrition and gut:liver interactions, and liver:environment/toxicant/drug interactions. The liver is the largest internal organ in the body, and is possibly the most complex organ in terms of metabolism.

  • It plays a vital role in protein, carbohydrate and fat as well as micronutrient metabolism, and it is the major site for drug and toxicant metabolism.
  • It protects the systemic circulation from gut-derived endotoxins, and it protects the body against a variety of environmental and drug-related insults.
  • It also plays a critical role in immune tolerance.

Liver diseases are some of the most common health problems afflicting Americans (and are frequently poorly recognized). Examples include NAFLD/NASH, ALD, Toxicant-Induced Liver Injury, HCC, viral hepatitis (e.g., Hepatitis C-HCV), and Drug-Induced Liver Injury/drug metabolism.

This COBRE brings together experienced senior mentors and promising junior investigators from across UofL in collaboration with scientists across the US/world to perform cross-cutting research on the unique topics of hepatobiology and toxicology. We evaluate critical barriers in our understanding of the development/progression of liver disease and we define targets for prevention/treatment that could transform current practice.

Specific Aims

  1. Develop a thematically-focused program in hepatobiology and toxicology that strengthens the overall research infrastructure at UofL.
  2. Create a multidisciplinary program in research education, mentoring and career development in hepatobiology and toxicology.
  3. Provide the necessary research resources and translational science/basic technologies to support and sustain state-of-the-art research in hepatobiology and toxicology.
  4. Discover new mechanisms/molecular targets and effective means for preventing and/or treating liver diseases/toxicant exposures and communicate our findings to the public.

External Advisory Committee